| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918194 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
High-dose fractionated reirradiation with IMRT offers 5-year disease control and OS in recurrent head-and-neck cancer for 1/3 and 1/4 patients, respectively. Severe late toxicity after 1-2 and 5Â years occurs in 1/4 and 2/3 patients, respectively.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fréderic Duprez, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, Wilfried De Neve,